Dennis Langer - Insider Trading & Ownership

Location
C/O Peter Tsoflias, Blank Rome Llp, One Logan Square, Fl 9, Philadelpha, PA
Summary
The estimated net worth of Dennis Langer is at least $2.17M dollars as of October 15, 2025. Dennis Langer is the Director of MYRIAD GENETICS INC and owns shares of MYRIAD GENETICS INC (MYGN) stock worth about $2.04M. Dennis Langer is the Director of Quoin Pharmaceuticals, Ltd. and owns shares of Quoin Pharmaceuticals, Ltd. (QNRX) stock worth about $129K.
Signature
/s/ Dennis Langer
All Insider Reports
All Insider Reports

Ownership of Dennis Langer

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
MYGN MYRIAD GENETICS INC Director $2.04M Jun 30, 2022
QNRX Quoin Pharmaceuticals, Ltd. Director $129K +$129K +1608000% Oct 14, 2025
ERNA Ernexa Therapeutics Inc. Director Dec 8, 2021

Insider Transactions Reported by Dennis Langer:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.